![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © 2007, European Molecular Biology Organization Foxo and Fos regulate the decision between cell death and survival in response to UV irradiation 1Department of Biology, University of Rochester, Rochester, NY, USA 2Institute of Biotechnology, University of Helsinki, Viikinkaari, Finland 3Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA aDepartment of Biology, University of Rochester, River Campus Box 270211, Rochester, NY 14627, USA. Tel.: +1 585 275 8973; Fax: +1 585 275 2070; E-mail: henri_jasper/at/urmc.rochester.edu Received July 12, 2006; Accepted November 8, 2006. This article has been cited by other articles in PMC.Abstract Cells damaged by environmental insults have to be repaired or eliminated to ensure tissue homeostasis in metazoans. Recent studies suggest that the balance between cell survival signals and pro-apoptotic stimuli controls the decision between cell repair and death. How these competing signals are integrated and interpreted to achieve accurate control over cell fate in vivo is incompletely understood. Here, we show that the Forkhead Box O transcription factor Foxo and the AP-1 transcription factor DFos are required downstream of Jun-N-terminal kinase signaling for the apoptotic response to UV-induced DNA damage in the developing Drosophila retina. Both transcription factors regulate the pro-apoptotic gene hid. Our results indicate that UV-induced apoptosis is repressed by receptor tyrosine kinase-mediated inactivation of Foxo. These data suggest that integrating stress and survival signals through Foxo drives the decision between cell death and repair of damaged cells in vivo. Keywords: apoptosis, DNA damage, Foxo, JNK, stress signaling Introduction Metazoans are able to maintain tissue homeostasis over a long period of time while under constant exposure to environmental challenges that damage macromolecules like DNA and proteins. Tight control of the decision between repair and salvage of damaged cells or elimination of such cells by programmed cell death (apoptosis) is crucial for this ability. It is becoming increasingly recognized that the integration and interpretation of extracellular death and survival cues by complex signal transduction networks ultimately controls such life or death decisions (Janes et al, 2005). However, it remains a challenge to identify and characterize the molecular mechanisms employed by cells to decode and respond to such competing signals in vivo. The developing Drosophila retina is an ideal system to study mechanisms that control cellular life/death decisions genetically. In the developing eye, tyrosine kinase signaling (mainly via the EGF receptor (EGFR)) is required to provide survival cues during photoreceptor differentiation (Bergmann et al, 1998b, 2002; Baker, 2001; Baker and Yu, 2001; Freeman and Bienz, 2001; Freeman, 2002; Brown and Freeman, 2003). EGFR signaling leads to activation of the Drosophila Ras homologue and protects cells against apoptosis. This effect is in part mediated by the MAPK ERK, which phosphorylates the pro-apoptotic protein Head Involution Defective (Hid) and thus induces its degradation (Bergmann et al, 1998a). A second mechanism to repress apoptosis downstream of EGFR signaling involves transcriptional repression of hid (Kurada and White, 1998). Apoptosis in the developing retina occurs naturally to shape the adult morphology of this highly ordered tissue (Baker, 2001), but can also be induced by genotoxic stress, for example by UV-induced DNA damage (Jassim et al, 2003). When repair of UV-induced DNA damage by photoreactivation is impaired, excessive apoptosis ensues and results in extensive damage to the fly's compound eye. Overexpression of caspase inhibitors reduces the morphological disruptions observed after UV irradiation, establishing the role of apoptosis in this effect. Furthermore, transcriptional upregulation of hid in response to UV-irradiation in the pupal retina has been reported, suggesting transcriptional induction of pro-apoptotic molecules as an important part of the DNA damage response in the eye (Jassim et al, 2003). An evolutionarily conserved regulatory system that influences cell survival and death in response to extracellular as well as intracellular cues is the stress-responsive Jun-N-terminal kinase (JNK) signaling pathway. A multitude of studies using cell culture systems and genetic model organisms have demonstrated that JNK plays an important role in apoptosis. However, JNK does not act universally as a pro-apoptotic signaling pathway, as JNK activation can also exert antiapoptotic activity in certain situations (Weston and Davis, 2002; Lamb et al, 2003; Lin, 2003; Liu and Lin, 2005; Ventura et al, 2006). The mechanism(s) by which the cellular response to JNK activation is determined is a subject of intense investigation. In a recent study, signaling interactions in cancer cells have been modeled using a systems biology approach, resulting in the identification and prediction of parameter sets that influence cellular life/death decisions as a function of JNK, EGF and insulin signaling activity (Janes et al, 2005). The models developed in these studies suggest that the strength of survival signals (EGF, insulin) determines the pro or antiapoptotic effect of JNK activation. Work in Drosophila melanogaster indicates that the pro-apoptotic as well as the prosurvival functions of JNK are evolutionarily conserved (Adachi-Yamada et al, 1999; Igaki et al, 2002; Moreno et al, 2002; Adachi-Yamada and O'Connor, 2004; de la Cova et al, 2004; Ryoo et al, 2004; McEwen and Peifer, 2005; Perez-Garijo et al, 2005; Uhlirova et al, 2005). As compared with mammals, the Drosophila system exhibits reduced genetic redundancy, which makes it easier to derive definitive answers to questions regarding signaling specificity as well as context-dependent responses to JNK activation. The JNK signaling pathway in flies consists, at its core, of the JNK kinase hemipterous (Hep), which is phosphorylated and activated by a variety of upstream JNKK kinases, and in turn activates the JNK Basket (Bsk) by phosphorylation. Bsk is known to phosphorylate transcription factors of the AP-1 family (mainly Djun and Dfos), thus regulating transcription. Drosophila AP-1 induces the transcription of the JNK-specific phosphatase Puckered (Puc), limiting the activity of JNK in a negative feedback loop. As in mammals, activation of the JNK pathway in flies is not always sufficient to induce apoptosis. JNK activity is, for example, required for morphogenetic processes during development, in which it regulates cellular shape changes (Harden, 2002). Moreover, JNK activation increases stress tolerance and longevity of flies (Wang et al, 2003, 2005). The molecular mechanisms that determine context- or cell type-specific cellular responses to JNK activation remain largely unknown. Transcription factors of the Forkhead Box O (Foxo) family play an important role in mediating apoptosis in a variety of cellular contexts (e.g. in B lymphocytes and neurons; Dijkers et al, 2000, 2002; Linseman et al, 2002; Accili and Arden, 2004; Greer and Brunet, 2005). Foxo factors are phosphorylated in response to cell survival signals by active Akt or IKK, and are consequently retained in the cytoplasm. When cells are deprived of survival signals, the Akt signal is reduced and Foxo translocates to the nucleus, where it can induce the expression of pro-apoptotic molecules such as the BH3-only Bcl2 family member Bim (Dijkers et al, 2000; Greer and Brunet, 2005). Foxo can, however, also induce gene expression programs with protective functions for the cell (Kops et al, 2002; Murphy et al, 2003). The mechanism that switches the cellular response to Foxo activation from apoptosis to survival remains unclear. Recently, a function for JNK in the regulation of Foxo activity has been identified in mammalian cells, Caenorhabditis elegans and Drosophila (Essers et al, 2004; Oh et al, 2005; Wang et al, 2005). This activation was shown to enhance oxidative stress resistance and longevity of the animal, but its role in the control of apoptosis has not been addressed. Interestingly, JNK signaling is known to induce Bim expression in neurons (Harris and Johnson, 2001; Whitfield et al, 2001), suggesting that Foxo might act downstream of JNK to promote apoptosis. Foxo is thus a prime candidate for an integrator of survival and stress signals in the control of cell homeostasis. In this study, we use UVC-mediated disruption of retinal morphogenesis of the fly eye as an in vivo model system for DNA damage-induced apoptosis (Jassim et al, 2003). We present genetic evidence that this apoptotic response is mediated by JNK/Foxo signaling. Furthermore, we show that Foxo and the AP-1 transcription factor DFos are required for UV-induced apoptosis, and that both factors control the transcription of hid. Consistent with the notion of Foxo acting as an integration point for competing survival/death signals in Drosophila cells, we find that UV-induced apoptosis is suppressed by cellular survival signaling through the EGFR/Ras and the InR/PI3K/Akt pathways. Results Induction of DNA damage by UVC irradiation of the pupal retina results in loss of eye tissue in the adult fly (Jassim et al, 2003). This phenotype is observed only when DNA repair by photoreactivation is impaired, and when the retina is exposed to UV between 23 and 24 h of pupal development. At this time point, the retina consists mainly of post-mitotic, differentiating cells. Studying UV-induced cell death in this system thus allows one to genetically dissect signaling pathways involved in DNA damage-induced cell death of post-mitotic tissues. Apoptotic response to UV-induced DNA damage in the Drosophila retina is mediated by JNK/Foxo signaling JNK is activated by UV irradiation, and studies in cell culture suggest that JNK signaling might play an important role in the control of apoptosis after DNA damage (van Dam et al, 1995; Tournier et al, 2000; Jassim et al, 2003; Hamdi et al, 2005). To test this hypothesis genetically, we examined whether JNK signaling is required for apoptosis in the retinal DNA damage response. We exposed the pupal retina of flies carrying the hep loss-of-function alleles hep1 or hepr75 to mild UVC irradiation (5 mJ/cm2 at 254 nm) and prevented photorepair by allowing subsequent pupal development to proceed in the dark. Comparing the phenotypic effects of this treatment on hep mutants and the corresponding wild-type controls (OreR) showed that reduction of hep function prevents excessive tissue loss (Figure 1A and B
UV irradiation induces hid expression in a JNK-dependent manner To specify the outcome of JNK signaling activity in vivo, additional signaling inputs have to exist that control pro-apoptotic signal transduction downstream of JNK. The mechanism(s) by which JNK induces apoptosis in flies is only beginning to be understood. Although direct activation of the mitochondrial pathway by JNK cannot be ruled out, recent studies in Drosophila support the notion that JNK signaling induces the transcription of pro-apoptotic molecules of the RGH (reaper, grim, hid) family, which inactivate the Drosophila inhibitor of apoptosis (DIAP) and thus induce caspase-mediated cell death (Moreno et al, 2002; McEwen and Peifer, 2005). We tested whether the requirement for JNK in UV-mediated apoptosis would correlate with transcriptional upregulation of pro-apoptotic molecules. Using a lacZ reporter line (Russell et al, 1998; Cox et al, 2000; Cullen and McCall, 2004; Sen et al, 2004), we found rapid induction of hid transcription in response to genotoxic UV irradiation (Figure 2A
We tested genetically whether hid might act downstream of JNK to induce apoptosis. Excessive JNK signaling during development of the retina, experimentally induced by the expression of constitutively active Hep (Hepact) in differentiating photoreceptors and cone cells (under the control of sepGal4), induces morphological defects that are caused by apoptosis (determined by TUNEL staining; Figure 2C and D Transcriptional control of apoptosis by Foxo and Fos downstream of JNK signaling Direct transcriptional control of hid downstream of JNK is likely to be achieved by the activation of JNK-responsive transcription factors. The AP-1 family members Jun and Fos (in Drosophila encoded by the jra and kayak genes, respectively) are canonical downstream transcription factors that respond to JNK signaling in a variety of physiological situations (Kockel et al, 2001). In addition, recent studies from our and other laboratories have established the forkhead transcription factor Foxo as a downstream effector of JNK signaling in flies, mice and worms (Essers et al, 2004; Oh et al, 2005; Wang et al, 2005). A role for Foxo in inducing apoptosis has been described in mammalian cells, in which Foxo-mediated transcriptional induction of pro-apoptotic molecules, such as Bim, has been found (Accili and Arden, 2004; Greer and Brunet, 2005). In vivo confirmation of such a pro-apoptotic role of Foxo has been elusive. To test whether AP-1 or Foxo acts downstream of JNK signaling in the control of apoptosis, we assessed whether JNK gain-of-function phenotypes in the eye are modulated when the gene dose of either dfoxo or the Dfos-encoding gene kayak (kay) is reduced. We found that introducing the dfoxo loss-of-function allele dfoxo21 (Junger et al, 2003; Puig et al, 2003) reduced the JNK gain-of-function phenotype (Figure 3A and B
Transcriptional regulation of hid by Foxo and Fos The requirement for Fos and Foxo in the UV-induced apoptotic response suggested that these transcription factors are involved in the UV-induced transcriptional induction of hid. Supporting such a role of Foxo, we observed activation of the hid gene when wild-type Foxo or Foxo™ (a constitutively nuclear form of Foxo which can not be phosphorylated by Akt; Junger et al, 2003; Puig et al, 2003; Hwangbo et al, 2004) was overexpressed in the larval retina (hid induction was observed using either hid-lacZ (Figure 4A)
As clusters of Foxo and AP-1 response elements are present in the first intron of the hid gene (Figure 4E Increasing Foxo expression in the fly retina (using the retinal driver GMR-Gal4) is sufficient to induce a weak phenotype that includes loss of ommatidia in the ventral areas as well as in the central midline of the eye (Figure 4H The genetic and biochemical results presented here suggest that binding by both Foxo and Fos to the first hid intron is required for JNK-induced apoptosis. Supporting this notion, the Foxo gain-of-function phenotype in the eye is reduced in a kay2 mutant background (Figure 4L Modulation of the apoptotic response by survival signaling Our data suggest that JNK-induced activation of Fos and Foxo and subsequent transcriptional induction of hid are required for DNA damage-induced apoptosis. At the same time, JNK-mediated activation of Foxo has beneficial effects for the organism, promoting stress tolerance and extending lifespan (Oh et al, 2005; Wang et al, 2005). These protective and pro-apoptotic roles of JNK and Foxo seem contradictory. Two possible explanations could reconcile these observations: (i) stress-induced apoptosis by JNK/Foxo signaling might be beneficial owing to the elimination of damaged cells that would otherwise contribute to deregulated overgrowth and consequent senescence of the organism. (ii) The effects of JNK/Foxo signaling might be context-dependent. Thus, activation of JNK and Foxo might elicit apoptotic responses only in conditions of severe cellular damage, whereas when cells are stressed, but able to adapt to the environment, the JNK/Foxo signaling axis might promote protective gene expression. This latter model has gained credence in recent years with the observation that JNK- as well as Foxo-induced apoptosis can be modulated by survival signals (Brunet et al, 2004; Janes et al, 2005). Foxo is negatively regulated by a number of survival signaling pathways, most notably signaling through Akt. Cells that receive abundant survival signals are thus expected to be resistant to JNK-mediated apoptosis. We tested this by analyzing whether the activity of EGFR or insulin receptor (InR) signaling would modulate JNK/Foxo-mediated apoptosis in the retina. EGFR signaling plays a crucial role in cell division and photoreceptor determination in the developing fly retina, but is also an important source for survival stimuli in differentiating neurons (Freeman and Bienz, 2001; Brown and Freeman, 2003). Similarly, InR signaling has been proposed to provide cell survival signals in the fly (Scanga et al, 2000). EGFR signals through Ras, which in turn activates a number of downstream signaling pathways, including phosphatidyl inositol 3 kinase (PI3K)—Akt signaling. Supporting a role for EGFR in preventing excessive apoptosis after JNK and Foxo activation, we found that a reduction in the EGFR or Ras gene dose dominantly enhanced JNK and Foxo gain-of-function phenotypes in the eye (Figure 5A–C and E–G
To test whether survival signals initiated by receptor tyrosine kinases would influence the apoptotic response to DNA damage, we assessed the extent of UV-induced morphological defects in the retina of EGFR and InR pathway mutants. We observed a marked increase in UV-induced apoptosis in flies heterozygous for ras or homozygous mutant for chico (Figure 5J, K and M–O Discussion Our results indicate that transcriptional regulation of hid is a crucial component to the DNA damage-induced apoptotic response in flies. The JNK-responsive transcription factors Foxo and Fos are both required for this response, suggesting that binding of both factors to their binding sites in the hid locus is required for hid induction. Thus, negative regulation of either of these factors would lead to repression of JNK-induced apoptosis (Figure 6
The requirement for Foxo in JNK-mediated apoptosis allows fine tuning of the decision between life and death of a cell, as the balance between Akt-mediated survival stimuli that inhibit Foxo activity and JNK-induced pro-apoptotic activation of Foxo would ultimately decide the cellular response to DNA damage. This interpretation is supported by our observation that UV-induced apoptosis in the pupal retina is influenced by the activities of the EGFR and insulin-signaling pathways and by the fact that overexpression of a mutant of Foxo that cannot be phosphorylated by Akt (and is therefore constitutively active) results in complete ablation of ommatidial structures. Mathematical models of signaling networks in cancer cells have predicted the importance of balancing survival signals and JNK activity for accurate control of the cellular decision between death and survival (Janes et al, 2005). Our work presented here validates these predictions in vivo and identifies the action of Foxo and Fos on the hid promoter as a crucial sensor and readout of this balance. How is the cellular response to JNK/Foxo signaling regulated? Our model proposes that JNK-mediated activation of Foxo leads to its nuclear translocation, where it activates pro-apoptotic gene expression. Interestingly, JNK signaling and Foxo activity have also been found to induce protective stress response molecules and damage repair proteins in flies as well as in C. elegans and mammalian cells, suggesting a role for Foxo in promoting cell repair and survival in response to stress (Kops et al, 2002; Murphy et al, 2003; Brunet et al, 2004; Wang et al, 2005). Evidently, the cellular context determines how a JNK/Foxo signal is interpreted. A variety of mechanisms governing the decision between Foxo-induced protective gene expression and Foxo-induced apoptosis can be envisioned. One candidate determinant of Foxo function is its acetylation status, which is influenced by the protein deacetylase Sir2 and which is believed to affect its promoter specificity (Brunet et al, 2004; Motta et al, 2004). Specific responses to JNK/Foxo activity could equally be achieved by the availability of transcriptional cofactors of Foxo that are required to selectively activate the expression of certain genes. Our results suggest that Fos is a pro-apoptotic transcriptional cofactor of Foxo in the fly. Among other recently identified cofactors of Foxo in mammalian cells and C. elegans are β catenin and SMK-1, both of which appear to be required for selected functions of Foxo and are thus prime candidates for additional specificity-providing inputs (Essers et al, 2005; Wolff et al, 2006). An alternative mechanism by which the decision between death and survival downstream of JNK could be controlled in vivo has been proposed (McEwen and Peifer, 2005). JNK-induced cell death might be governed by a timing mechanism, in which short-term activation of JNK (which is normally inhibited by a negative feedback loop involving Puc) would allow cell repair, whereas long-term activation would lead to cell death. Such a time-dependent cellular response to JNK activation has been observed in mammalian cells (Karin and Gallagher, 2005; Ventura et al, 2006). It could explain why apoptosis in the eye is observed only when photorepair is deficient (and thus JNK is active for a long period of time), but not when JNK is activated transiently by UV, but DNA is repaired. In this model, the activity of EGFR/Akt signaling might change the threshold that distinguishes between pro-apoptotic and prorepair functions of JNK/Foxo signaling. Accurate understanding of the above-mentioned mechanisms and their importance for the regulation of cell fate in vivo is required to gain insight into how organisms fend off environmental insults and is imperative for understanding disease processes like cellular senescence during aging or cancer. Materials and methods Fly strains and handling The following fly stocks were obtained from the Bloomington Stock Center: OreR, w1118, W05014, Df(H99), rase1B, chico1 and argosdelta-7. hep1/FM6 was a gift from S Noselli; pucE69 was a gift from E Martín-Blanco; UASHepact, GMRGal4 and sepGal4 were gifts from M Mlodzik; Dfoxo21/TM3 and Dfoxo25/TM3 were gifts from E Hafen; UASpro.DroncCtoA was a gift from G Evan; UASDfoxo is described in Puig et al (2003); UASDFoxo™ was a gift from Marc Tatar (Hwangbo et al, 2004). Other fly strains are as described: UASfosRNAi (Hyun et al, in preparation); hs-fos and kay2/TM3 (Zeitlinger and Bohmann, 1999). In the transient overexpression experiments, flies were raised at room temperature (21°C). Wandering third instar larva were collected and heat-shocked at 37°C for 1 h and subsequently kept at room temperature for another 2 h. Pupal UV irradiation and phenotype quantification Mid-aged pupae (24 h after puparium formation) were collected and subjected to surgical removal of the pupal shell surrounding the head area. UV irradiation was carried out on larvae that were immobilized on the side, so that only one retina was exposed to UV. A UV crosslinker (Stratalinker, 1800) was used with energy set at 5 mJ/cm2. After irradiation, pupae were kept in the dark until being processed. The images of UV-damaged adult eyes were taken from the top so that both eyes were visible. The boundary of each eye was outlined using Photoshop. The eye size was determined by measuring the number of pixels contained within this area. Ratios between the area of irradiated and non-irradiated eyes were then determined. TUNEL staining TUNEL stainings were performed using the ApopTag kit (Chemicon International) following the instructions. RT–PCR Twenty wing or eye imaginal discs were collected for each RNA extraction. Total RNA was isolated using TRIzol (Invitrogen), and RT–PCR was performed as previously described (Jasper et al, 2001; Wang et al, 2003). Primers include hid (sense, 5′-TGCGAAATA CACGGGTTCA-3′ and antisense 5′-CCAATATCACCCAGTCCCG-3′) puc (sense, 5′-CGAGGATGGGTTTGATTACGA-3′, and antisense, 5′-TCAGTCCCTCGTCAAATTGCT-3′) and rp49 (sense, 5′-TCCTAC CAGCTTCAAGATGAC-3′ and antisense, 5′-CACGTTGTGCACCAG GAACT-3′) Beta-gal staining Samples were fixed in 1% glutaraldehyde at room temperature and washed with PBS+2 mM MgCl2. The staining solution contained 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6 and 0.1% X-gal. Stainings were performed at 30 or 37°C for 48 or 24 h, respectively. Chromatin immunoprecipitation Chromatin from continuously dividing S2 cells was collected according to the protocol of a commercial ChIP assay kit (Upstate Biotechnologies). Rabbit anti-D-Fos antibody (Ciapponi et al, 2001) was used for immunoprecipitation. Promoter regions with or without AP-1 sites of puc, and hsp26 were detected in the precipitated material by PCR using the following primer sets: hid (5′-ATTGTGTGGGTTAATCAGGA-3′ and 5′-TTGTAAGATTCCCAC TTTGG-3′); hsp26 (5′-TTAATAAAGAGGAAAACCAG-3′ and 5′-AA AAATAAAACTAACTAACCTT-3′); and puc (5′-GGTTTGAGCCCGA GATAA-3′ and 5′-ACTGAAGACTTTGCGGTTGAA-3′); see also Lee et al (2005). ChIP assays for Foxo were performed as described (Puig et al, 2003), using an anti-DFoxo antibody and the following primers: hid (5′-TTTGCTGATAAGCTGACAAAGTGCTG-3′ and 5′-CAAGAAGGA TTTTCATAGGATCTCCTTG-3′) and U6 snRNA (5′-GCAGAGGGTTCTTAAGACCATTTGCC-3′ and 5′-GCTTCACGATTTTGCGTGTCATCC-3′). Acknowledgments We thank Benoît Biteau and Mette D Nielsen for critical reading of the manuscript, and Willis X Li and members of his lab for discussion. We are grateful to E Hafen, M Mlodzik, E Martín-Blanco, S Noselli, G Evan and the Bloomington Stock Center for sharing fly lines. This work was supported by a grant from the Upstate Coalition for Aging Research—American Federation for Aging Research to HJ. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Science. 2005 Dec 9; 310(5754):1646-53.
[Science. 2005]Oncogene. 1998 Dec 24; 17(25):3215-23.
[Oncogene. 1998]Dev Cell. 2002 Feb; 2(2):159-70.
[Dev Cell. 2002]Semin Cell Dev Biol. 2001 Dec; 12(6):499-507.
[Semin Cell Dev Biol. 2001]Cell. 2001 Mar 9; 104(5):699-708.
[Cell. 2001]EMBO Rep. 2001 Feb; 2(2):157-62.
[EMBO Rep. 2001]Semin Cell Dev Biol. 2001 Dec; 12(6):499-507.
[Semin Cell Dev Biol. 2001]EMBO J. 2003 Oct 15; 22(20):5622-32.
[EMBO J. 2003]Curr Opin Genet Dev. 2002 Feb; 12(1):14-21.
[Curr Opin Genet Dev. 2002]Mol Cell. 2003 Jun; 11(6):1479-89.
[Mol Cell. 2003]Bioessays. 2003 Jan; 25(1):17-24.
[Bioessays. 2003]Cell Res. 2005 Jan; 15(1):36-42.
[Cell Res. 2005]Mol Cell. 2006 Mar 3; 21(5):701-10.
[Mol Cell. 2006]Nature. 1999 Jul 8; 400(6740):166-9.
[Nature. 1999]EMBO J. 2002 Jun 17; 21(12):3009-18.
[EMBO J. 2002]Curr Biol. 2002 Jul 23; 12(14):1263-8.
[Curr Biol. 2002]J Biochem. 2004 Jul; 136(1):13-7.
[J Biochem. 2004]Cell. 2004 Apr 2; 117(1):107-16.
[Cell. 2004]Differentiation. 2002 Jun; 70(4-5):181-203.
[Differentiation. 2002]Dev Cell. 2003 Nov; 5(5):811-6.
[Dev Cell. 2003]Cell. 2005 Apr 8; 121(1):115-25.
[Cell. 2005]Curr Biol. 2000 Oct 5; 10(19):1201-4.
[Curr Biol. 2000]J Cell Biol. 2002 Feb 4; 156(3):531-42.
[J Cell Biol. 2002]J Neurosci. 2002 Nov 1; 22(21):9287-97.
[J Neurosci. 2002]Cell. 2004 May 14; 117(4):421-6.
[Cell. 2004]Oncogene. 2005 Nov 14; 24(50):7410-25.
[Oncogene. 2005]EMBO J. 2004 Dec 8; 23(24):4802-12.
[EMBO J. 2004]Proc Natl Acad Sci U S A. 2005 Mar 22; 102(12):4494-9.
[Proc Natl Acad Sci U S A. 2005]Cell. 2005 Apr 8; 121(1):115-25.
[Cell. 2005]J Biol Chem. 2001 Oct 12; 276(41):37754-60.
[J Biol Chem. 2001]Neuron. 2001 Mar; 29(3):629-43.
[Neuron. 2001]EMBO J. 2003 Oct 15; 22(20):5622-32.
[EMBO J. 2003]EMBO J. 2003 Oct 15; 22(20):5622-32.
[EMBO J. 2003]EMBO J. 1995 Apr 18; 14(8):1798-811.
[EMBO J. 1995]Science. 2000 May 5; 288(5467):870-4.
[Science. 2000]EMBO J. 2003 Oct 15; 22(20):5622-32.
[EMBO J. 2003]Oncogene. 2005 Nov 3; 24(48):7135-44.
[Oncogene. 2005]Curr Biol. 2002 Jul 23; 12(14):1263-8.
[Curr Biol. 2002]Development. 2005 Sep; 132(17):3935-46.
[Development. 2005]Genome. 1998 Feb; 41(1):7-13.
[Genome. 1998]Genetics. 2000 Aug; 155(4):1725-40.
[Genetics. 2000]Dev Biol. 2004 Nov 1; 275(1):82-92.
[Dev Biol. 2004]Mech Dev. 2004 Jan; 121(1):65-78.
[Mech Dev. 2004]Oncogene. 2001 Apr 30; 20(19):2347-64.
[Oncogene. 2001]EMBO J. 2004 Dec 8; 23(24):4802-12.
[EMBO J. 2004]Proc Natl Acad Sci U S A. 2005 Mar 22; 102(12):4494-9.
[Proc Natl Acad Sci U S A. 2005]Cell. 2005 Apr 8; 121(1):115-25.
[Cell. 2005]Cell. 2004 May 14; 117(4):421-6.
[Cell. 2004]J Biol. 2003; 2(3):20.
[J Biol. 2003]Genes Dev. 2003 Aug 15; 17(16):2006-20.
[Genes Dev. 2003]Mol Cell Biol. 2006 Nov; 26(22):8293-302.
[Mol Cell Biol. 2006]Development. 1999 Sep; 126(17):3947-56.
[Development. 1999]J Biol. 2003; 2(3):20.
[J Biol. 2003]Genes Dev. 2003 Aug 15; 17(16):2006-20.
[Genes Dev. 2003]Nature. 2004 Jun 3; 429(6991):562-6.
[Nature. 2004]Science. 2003 Dec 5; 302(5651):1765-8.
[Science. 2003]J Biol. 2003; 2(3):20.
[J Biol. 2003]Genes Dev. 2003 Aug 15; 17(16):2006-20.
[Genes Dev. 2003]EMBO J. 2000 Feb 15; 19(4):598-611.
[EMBO J. 2000]Proc Natl Acad Sci U S A. 2005 Mar 22; 102(12):4494-9.
[Proc Natl Acad Sci U S A. 2005]Cell. 2005 Apr 8; 121(1):115-25.
[Cell. 2005]Science. 2004 Mar 26; 303(5666):2011-5.
[Science. 2004]Science. 2005 Dec 9; 310(5754):1646-53.
[Science. 2005]EMBO Rep. 2001 Feb; 2(2):157-62.
[EMBO Rep. 2001]Development. 2003 Nov; 130(22):5401-12.
[Development. 2003]Oncogene. 2000 Aug 17; 19(35):3971-7.
[Oncogene. 2000]Science. 2005 Dec 9; 310(5754):1646-53.
[Science. 2005]Nature. 2002 Sep 19; 419(6904):316-21.
[Nature. 2002]Nature. 2003 Jul 17; 424(6946):277-83.
[Nature. 2003]Science. 2004 Mar 26; 303(5666):2011-5.
[Science. 2004]Cell. 2005 Apr 8; 121(1):115-25.
[Cell. 2005]Cell. 2004 Feb 20; 116(4):551-63.
[Cell. 2004]Science. 2005 May 20; 308(5725):1181-4.
[Science. 2005]Cell. 2006 Mar 10; 124(5):1039-53.
[Cell. 2006]Development. 2005 Sep; 132(17):3935-46.
[Development. 2005]IUBMB Life. 2005 Apr-May; 57(4-5):283-95.
[IUBMB Life. 2005]Mol Cell. 2006 Mar 3; 21(5):701-10.
[Mol Cell. 2006]Genes Dev. 2003 Aug 15; 17(16):2006-20.
[Genes Dev. 2003]Nature. 2004 Jun 3; 429(6991):562-6.
[Nature. 2004]Development. 1999 Sep; 126(17):3947-56.
[Development. 1999]Dev Cell. 2001 Oct; 1(4):579-86.
[Dev Cell. 2001]Dev Cell. 2003 Nov; 5(5):811-6.
[Dev Cell. 2003]Genes Dev. 2001 Jun 15; 15(12):1540-53.
[Genes Dev. 2001]Nature. 2005 Nov 10; 438(7065):234-7.
[Nature. 2005]Genes Dev. 2003 Aug 15; 17(16):2006-20.
[Genes Dev. 2003]EMBO J. 2003 Oct 15; 22(20):5622-32.
[EMBO J. 2003]Genes Dev. 2002 Jun 15; 16(12):1568-81.
[Genes Dev. 2002]Genome. 1998 Feb; 41(1):7-13.
[Genome. 1998]Genetics. 2000 Aug; 155(4):1725-40.
[Genetics. 2000]Dev Biol. 2004 Nov 1; 275(1):82-92.
[Dev Biol. 2004]Mech Dev. 2004 Jan; 121(1):65-78.
[Mech Dev. 2004]Dev Cell. 2002 Oct; 3(4):511-21.
[Dev Cell. 2002]Science. 2003 Dec 5; 302(5651):1765-8.
[Science. 2003]Nature. 2005 Nov 10; 438(7065):234-7.
[Nature. 2005]Genes Dev. 2003 Aug 15; 17(16):2006-20.
[Genes Dev. 2003]EMBO J. 2000 Feb 15; 19(4):598-611.
[EMBO J. 2000]